Retardation of myopia by atropine regimes
Myopia is a huge health problem due to its high frequency, vision losses and public health cost. According to the World Health Organization, at least 2.2 billion people have vision impairment. Although myopia can be controlled at its early and middle stages, unfortunately, no cure can be achieved so...
Autors principals: | Qin Zhu, Li Chen, Jia-Rui Liang, Min Hu, Li-Ping Xue, Guang-Long Zhou, Yuan Zhou, Jie-Ying Zhang, David Fernandez-Hazoury, Allison Helman, Ying-Ting Zhu, Xiao-Fan Zhang |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Press of International Journal of Ophthalmology (IJO PRESS)
2024-11-01
|
Col·lecció: | International Journal of Ophthalmology |
Matèries: | |
Accés en línia: | http://ies.ijo.cn/en_publish/2024/11/20241120.pdf |
Ítems similars
-
Atropine in the treatment of childhood myopia
per: Sanitha Sathyan
Publicat: (2019-01-01) -
The Role of Atropine in Preventing Myopia Progression: An Update
per: Alberto Chierigo, et al.
Publicat: (2022-04-01) -
Consensus statement and guidelines for use of dilute atropine sulphate in myopia control
per: Siddharth S Kesarwani, et al.
Publicat: (2019-01-01) -
The use of atropine in childhood myopia: Experience in Indian eyes
per: Sanitha Sathyan
Publicat: (2019-01-01) -
Myopia control utilizing low-dose atropine as an isolated therapy or in combination with other optical measures: A retrospective cohort study
per: Nir Erdinest, et al.
Publicat: (2023-01-01)